Warner Chilcott Sues Mylan Over Loestrin ANDA

Law360, New York (June 9, 2011, 8:17 PM EDT) -- Warner Chilcott Co. LLC filed a patent infringement suit in New Jersey on Thursday seeking to stop Mylan Inc. from releasing a generic form of birth control pill Loestrin.

Warner Chilcott filed the complaint against Mylan Inc., its wholly owned subsidiary Mylan Pharms Inc. and an Indian drug company called Famy Care Ltd., which has a manufacturing agreement with Mylan.

The plaintiff accused Mylan of submitting an abbreviated new drug application for a generic form of the birth control pill before Warner Chilcott's patent on the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.